PREDIVAC: CD4+ T-cell epitope prediction for vaccine design that covers 95% of HLA class II DR protein diversity

Patricio OyarzĂșn, Jonathan J. Ellis, Mikael BodĂ©n, Bostjan Kobe. PREDIVAC: CD4+ T-cell epitope prediction for vaccine design that covers 95% of HLA class II DR protein diversity. BMC Bioinformatics, 14:52, 2013. [doi]

Abstract

Abstract is missing.